|Title||Gastroenterology and Hepatology- 2017 Ferring Innovation Grants|
|Opportunity Type||Grants and Funding|
Gastroenterology and Hepatology- 2017 Ferring Innovation Grants
Deadline: June 12, 2017
Ferring is interested in funding exploratory, discovery and preclinical research into novel drug targets that are addressable with peptides and/or proteins.
The Ferring Innovation Grants are awarded annually in December and are not renewable. We will NOT fund clinical studies, proposals that require the collection of patient biopsies or studies to develop small molecules or intracellular targets.
Ferring is committed to building a portfolio of novel, innovative peptide-based drugs and biologicals to address the high unmet medical need for patients in our therapeutic areas of interest.
TRIALECT IS PROUD TO LET YOU KNOW THAT 7 OUT OF 11 AWARDEES LAST YEAR WERE TRIALECT REGISTERED MEMBERS
|Field of Interest||gastroenterology, Gut microbiata, microbiome, hepatology, celiac disease, inflammatory bowel diseases, ulcerative colitis, Crohn's disease, non alcoholic steatohepatitis|
|Uploaded Sponsor Image|
|Sponsor Name||Ferring Pharmaceuticals|